← Back to all trials
Recruiting
NCT05704517
Progressive Familial Intrahepatic Cholestasis in Indian Children - Establishing an Indian PFIC Registry
Conditions: Progressive Familial Intrahepatic Cholestasis
Sex: All
Ages: N/A – 18 Years
Enrollment: 200
Sponsor: Institute of Liver and Biliary Sciences, India
Location: India
Summary
The project will amalgamate data from several large Indian centers to describe the genotype, clinical spectrum, natural course, genotype-phenotype correlation, outcome, and response to medical therapy in Indian children with progressive familial intrahepatic cholestasis (PFIC).
This will be the first such Indian registry of children with PFIC.
There are currently limited single-center studies describing the genotype, natural course, and outcome of Indian children with PFIC.Data will be collected retrospectively from the participating centers across the country.
Only genetically confirmed cases would be included.
Eligibility Criteria
Inclusion Criteria:Genetically proven homozygous or compound heterozygous mutations of ATP8B1/ ABCB11/ ABCB4/ TJP2/ NR1H4/ MYO5B/ USP53/ KIF12 ANDClinical and biochemical evidence of chronic cholestatic disease AND / ORHistological features of intrahepatic cholestasis with suggestive immunohistochemistryExclusion Criteria:Genetic analysis showing mutations unrelated to intrahepatic cholestasis according to databaseClinical, biochemical, and histological evidence of progressive familial intrahepatic cholestasis without a genetic sequencing report
Source: ClinicalTrials.gov (NCT05704517). StuddyBuddy aggregates publicly available trial information.